DE60040784D1 - Verfahren zur behandlung von inkontinenz - Google Patents

Verfahren zur behandlung von inkontinenz

Info

Publication number
DE60040784D1
DE60040784D1 DE60040784T DE60040784T DE60040784D1 DE 60040784 D1 DE60040784 D1 DE 60040784D1 DE 60040784 T DE60040784 T DE 60040784T DE 60040784 T DE60040784 T DE 60040784T DE 60040784 D1 DE60040784 D1 DE 60040784D1
Authority
DE
Germany
Prior art keywords
incontinence
treatment
gamma
instant invention
aminobutyric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60040784T
Other languages
English (en)
Inventor
Catherine A Segal
Leslie Magnus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22434891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60040784(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE60040784D1 publication Critical patent/DE60040784D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60040784T 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz Expired - Lifetime DE60040784D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12834799P 1999-04-08 1999-04-08
PCT/US2000/002141 WO2000061135A1 (en) 1999-04-08 2000-01-27 Method for the treatment of incontinence

Publications (1)

Publication Number Publication Date
DE60040784D1 true DE60040784D1 (de) 2008-12-24

Family

ID=22434891

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60044160T Expired - Lifetime DE60044160D1 (de) 1999-04-08 2000-01-27 Behandlung von Inkontinenz
DE60040784T Expired - Lifetime DE60040784D1 (de) 1999-04-08 2000-01-27 Verfahren zur behandlung von inkontinenz

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60044160T Expired - Lifetime DE60044160D1 (de) 1999-04-08 2000-01-27 Behandlung von Inkontinenz

Country Status (13)

Country Link
EP (2) EP1977745B1 (de)
JP (1) JP2002541198A (de)
KR (1) KR20010103053A (de)
AT (2) ATE413872T1 (de)
AU (2) AU779262B2 (de)
CA (1) CA2362026A1 (de)
DE (2) DE60044160D1 (de)
ES (2) ES2341059T3 (de)
HU (1) HUP0200738A3 (de)
IL (1) IL145763A0 (de)
TR (1) TR200102837T2 (de)
WO (1) WO2000061135A1 (de)
ZA (1) ZA200107425B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
JP2006511606A (ja) * 2002-12-13 2006-04-06 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 下部尿路症状を治療するα−２−δリガンド
EP1621193A3 (de) * 2002-12-20 2006-08-02 Dynogen Pharmaceuticals Inc. Behandlung nicht-schmerzhafter Blasenstörungen mit Kalziumkanalmodulatoren der alpha2-delta-Untereinheit
EP1480631B1 (de) * 2002-12-20 2007-08-01 Dynogen Pharmaceuticals Inc. Behandlung nicht-schmerzhafter blasenstörungen mit modulatoren von alpha-2-delta- calciumkanaluntereinheiten
JP2006520799A (ja) * 2003-03-21 2006-09-14 ダイノジェン ファーマシューティカルズ， インコーポレイテッド 平滑筋調節因子およびα２δサブユニットカルシウムチャネル調節因子を用いた、下部尿路障害を処置するための方法
WO2005025562A1 (en) * 2003-09-11 2005-03-24 Xenoport, Inc. Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
KR101096480B1 (ko) 2003-10-14 2011-12-20 제노포트 인코포레이티드 감마-아미노부티르산 유사체의 결정질 형태
EA017171B1 (ru) * 2006-12-22 2012-10-30 Рекордати Айерленд Лимитед КОМБИНИРОВАННАЯ ТЕРАПИЯ ЗАБОЛЕВАНИЙ НИЖНИХ МОЧЕВЫВОДЯЩИХ ПУТЕЙ С ИСПОЛЬЗОВАНИЕМ ЛИГАНДОВ αδ И НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ (НПВП)
EP2240158A2 (de) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilisierte injizierbare pregabalin-formulierung
TWI369202B (en) 2008-01-25 2012-08-01 Xenoport Inc Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
EP2250148B1 (de) 2008-01-25 2016-08-17 XenoPort, Inc. Kristalline form von kalziumsalzen von (3s)-aminomethyl-5-methylhexansäuren und anwendungsverfahren
ES2423254B1 (es) * 2012-02-15 2014-03-26 Laboratec, S.L. Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9137091A (en) * 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
RU2140901C1 (ru) * 1992-05-20 1999-11-10 Нортвестерн Юниверсити АНАЛОГИ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ, СПОСОБ ЛЕЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US20020045742A1 (en) * 1998-12-15 2002-04-18 Kenneth A. Jones Dna encoding a gaba b r2 polypeptide and uses thereof

Also Published As

Publication number Publication date
EP1171114B1 (de) 2008-11-12
HUP0200738A2 (hu) 2002-07-29
HUP0200738A3 (en) 2003-03-28
ATE463242T1 (de) 2010-04-15
DE60044160D1 (de) 2010-05-20
WO2000061135A1 (en) 2000-10-19
ATE413872T1 (de) 2008-11-15
ES2341059T3 (es) 2010-06-14
EP1977745B1 (de) 2010-04-07
JP2002541198A (ja) 2002-12-03
KR20010103053A (ko) 2001-11-17
EP1171114A1 (de) 2002-01-16
AU779262C (en) 2000-11-14
ZA200107425B (en) 2003-02-26
CA2362026A1 (en) 2000-10-19
EP1977745A1 (de) 2008-10-08
TR200102837T2 (tr) 2002-03-21
AU2005200619A1 (en) 2005-03-10
IL145763A0 (en) 2002-07-25
ES2313880T3 (es) 2009-03-16
AU779262B2 (en) 2005-01-13
AU2741600A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
DE60040784D1 (de) Verfahren zur behandlung von inkontinenz
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
DE69319270D1 (de) Verfahren zur Behandlung von organischen Schlämmen
DE69535498D1 (de) Verfahren zur behandlung vaskulärer kopfschmerzen
DE59807122D1 (de) Verwendung von fumarsäurederivaten zur behandlung von autoimmunerkrankungen
WO2000002546A3 (en) Use of caba-analogues for treating insomnia
DE60138129D1 (de) Apparat zur behandlung von zähnen
ATE522229T1 (de) Anti-ngf-antikörper zur behandlung verschiedener erkrankungen
ATE271385T1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
DE69736443D1 (de) Verfahren zur Behandlung von rostfreien Stahlschlacken
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
DE60212613D1 (de) Doxycyclin zur behandlung von akne
ATE239457T1 (de) Verfahren zur prophylaktischen behandlung von mastitis
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATA17552001A (de) Verfahren zur behandlung säurehältiger abwässer
PL344580A1 (en) Aza-heterocyclic compounds used to treat neurological disorders and hair loss
FI864246A0 (fi) N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DE59908511D1 (de) Verfahren zur peroxidischen Behandlung von Olefinpolymerisaten
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE60214361D1 (de) Verfahren zur herstellung von gallensäure
DE69524479T2 (de) Verfahren zur Behandlung von sauren Abgasen
DE69736180D1 (de) Behandlung von manischen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition